Dr. Michael Morris, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Prostate Cancer
Studies Pancreatic Cancer
13 reported clinical trials
20 drugs studied
Area of expertise
1Prostate Cancer
GRPR positive
Stage IV
BRCA positive
2Pancreatic Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Michael Morris, MD is currently running
68Ga PSMA-PET/CT Scan
for Bladder Cancer
The purpose of this study is to see whether 68Gallium PSMA-PET/CT scans are an effective way to detect sites of cancer in people with metastatic bladder cancer or skin cancer. The study researchers want to learn if a 68Gallium PSMA PET/CT scan will work better, the same, or not as well as the PET/CT scans doctors usually use for imaging bladder cancer or skin cancer (FDG-PET/CT scan).
Recruiting1 award Phase 15 criteria
A&M Breathalyzer
for COVID-19
The primary objective of this effort will be to optimize and operationalize innovative passive surveillance systems and in parallel, the effort will identify, evaluate, and transition groundbreaking new technologies in diagnostics for operationalization. To meet the objective and execute the deliverables for this program of effort, the A\&M Breathalyzer PROTECT Kiosk will be tested, modified and validated at Brooke Army Medical Center (BAMC). The collaborative efforts between the PI, Dr. Michael Morris at BAMC and Co-Investigator Dr. Tony Yuan at USU- Center for Biotechnology (4D Bio3) will assess the passive detection technology and provide a capability survey of use-case scenarios for different operational settings. Goals: 1. Optimization and operationalize the A\&M Breathalyzer PROTECT Kiosk, portable mass spectrometer (MS) Detector for Deployment in Military Operational Medicine Environments. The Breathalyzer will be deployed to BAMC to test its detection capabilities of COVID-19 among symptomatic and asymptomatic COVID-19 carrier vs. those not infected compared to gold standard RT-PCR. 2. Evaluate the passive sensing, breath capture system, built within the A\&M Breathalyzer PROTECT Kiosk. The conversion of the active breath capture system, currently requires a straw that the subject breaths into, where then a series of sensors built in the Breathalyzer would automatically sample the exhaled breath within proximity for recent COVID-19 exposure. This task would conclude with a set of sensors and sensor inputs that would be analyzed by the Atomic AI platform built in the device. Field testing at BAMC is planned to determine the level of detection and discrimination for sensor combinations to SARS-CoV2 components and biomarkers detected. This testing would update the Atomic AI algorithm, within the device, to understand the accuracy of positive detection and the resulting sensitivities.
Recruiting1 award N/A4 criteria
More about Michael Morris, MD
Clinical Trial Related3 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Michael Morris, MD has experience with
- Docetaxel
- Radium-223
- -[18F] Dihydro-Testosterone
- [18F]-Fluoro-2-Deoxy-D-Glucose
- [68Ga]PSMA
- 89Zr-girentuximab
Breakdown of trials Michael Morris, MD has run
Prostate Cancer
Breast Cancer
Transitional Cell Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Morris, MD specialize in?
Michael Morris, MD focuses on Prostate Cancer and Pancreatic Cancer. In particular, much of their work with Prostate Cancer has involved GRPR positive patients, or patients who are Stage IV.
Is Michael Morris, MD currently recruiting for clinical trials?
Yes, Michael Morris, MD is currently recruiting for 8 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michael Morris, MD has studied deeply?
Yes, Michael Morris, MD has studied treatments such as Docetaxel, Radium-223, -[18F] Dihydro-Testosterone.
What is the best way to schedule an appointment with Michael Morris, MD?
Apply for one of the trials that Michael Morris, MD is conducting.
What is the office address of Michael Morris, MD?
The office of Michael Morris, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.